Submitted: 19 Jun 2022
Accepted: 22 Sep 2022
ePublished: 08 Oct 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Endocrinol. 2022;8: e17069.
doi: 10.34172/jre.2022.17069
  Abstract View: 71
  PDF Download: 39

Original Article

ACE I/D polymorphism is not a genetic modifier of renal features in sickle cell anemia patients

LVKS Bhaskar 1* ORCID logo, Smaranika Pattnaik 2

1 Department of Zoology, Guru Ghasidas Vishwavidyalaya, Koni, Bilaspur, India.
2 Department of Biotechnology and Bioinformatics, Sambalpur University, Jyoti Vihar, Sambalpur, India.
*Corresponding Author: Corresponding Author: Prof. LVKS Bhaskar, Email: , Email: lvksbhaskar@gmail.com


Introduction: Sickle cell anemia (SCA) exhibits a host of complications that contribute to increased morbidity and mortality at the youngest ages.

Objectives: The aim of this investigation is to look into the association between ACE I/D polymorphism and renal function in Indian patients with SCA.

Patients and Methods: About 190 SCA patients confirmed by hemoglobin (Hb) electrophoresis were selected for this study. The severity of the disease was determined using anemia, clinical complications, total white blood cells count, and scores of blood transfusion. To define different renal function phases, estimated glomerular filtration rate (eGFR) was computed in adults and children using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) and Schwartz equations respectively. The ACE I/D polymorphism was conducted using polymerase chain reaction (PCR) and separation through agarose electrophoresis.

Results: The risk of impaired renal function was not statistically distinct between ACE I/D genotypes and alleles. Further, the genotypes of ACE I/D and the risk of disease severity was not found to be associated with each other.

Conclusion: This investigation found that ACE I/D is an insignificant genetic modifier of renal function or severity of disease in patients with SCA.

Citation: Bhaskar L, Pattnaik S. ACE I/D polymorphism is not a genetic modifier of renal features in sickle cell anemia patients. J Ren Endocrinol. 2022;8:e17069. doi: 10.34172/jre.2022.17069.
First Name
Last Name
Email Address
Security code

Abstract View: 72

Your browser does not support the canvas element.

PDF Download: 39

Your browser does not support the canvas element.